Skip to main content
Equibles

Mark Conley

CFO

SAB Biotherapeutics, Inc. (SABS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Mark Conley

Mark Conley is recorded as CFO at SAB Biotherapeutics, Inc. (SABS). SAB Biotherapeutics, Inc. reported in an 8-K filed May 31, 2024 that Mark Conley was appointed Interim Chief Financial Officer, effective June 4, 2024.

“On May 30, 2024, Mark Conley, 62, was appointed Interim Chief Financial Officer of SAB Biotherapeutics, Inc., a Delaware corporation (the “Company”), effective June 4, 2024.”
SAB Biotherapeutics, Inc. Form 8-K, filed May 31, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at SAB Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.